Document ID: chunk:federal_register_of_legislation:F2012L02518:schedule:1
Version: federal_register_of_legislation:F2012L02518
Segment Type: schedule
Provision Reference: sch 1
Character Range: 977–2265

Schedule 1
1.  Functions

       (i)                  By 30 June 2013, the Pricing Authority must determine the national efficient price for a list of standard items (provided to it by the National Health and Medical Research Council) associated with conducting clinical trials in Australia.

       (ii)                 At the first meeting of the Standing Council on Health after 30 June 2013, the Pricing Authority must provide a report on its performance of the activity referred to in Item 1(i) of this Direction to the Minister for Health and Ageing and to the Minister having responsibility for health in each State and Territory.

2. Matters the Pricing Authority is to have regard to

       (i)                  In performing the activity described in Item 1 of this Schedule, the Pricing Authority must have regard to the matters set out in subsection 131(3) of the Act.

       (ii)                In addition, the Pricing Authority may, so far as the Act permits, have regard to the following matters:
              (a)                     The actual activity of each item;
              (b)                     Principles of cost-recovery; and
              (c)                     Submissions from relevant parties, including clinical trial sponsors and private hospitals.